Clinical Trial Update: Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection [NA]

View source ↗

Summary

A completed study from Charité University evaluated donor-derived cell-free DNA as an early diagnostic biomarker for antibody-mediated rejection in kidney trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody-mediated Rejection
• Kidney Transplant Failure
• Kidney Transplant Rejection

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Kidney Transplant Rejection, Antibody-mediated Rejection | NA | Status: COMPLETED